PISCATAWAY, N.J., Sept. 8, 2025 \/PRNewswire\/ — Cell and gene therapies (CGT) are advancing rapidly and are reshaping the future of medicine. From CRISPR-based genome editing to new applications of in vivo and ex vivo cell therapies, scientific breakthroughs are increasingly moving from the laboratory into clinical practice. At the same time, global investment and innovation in the field are accelerating, positioning CGT as one of the fastest-growing areas in life sciences.<\/p>\n
One of the greatest challenges for the industry lies in translating these advances into lasting patient benefits and sustainable clinical impact. To address the opportunities and challenges of this evolving landscape, the GenScript Biotech Global Forum London 2025 <\/b>will take place on November 20th, 2025<\/b>, in London, United Kingdom, alongside the Jefferies London Healthcare Conference.<\/b> Under the theme “THE NEXT ERA OF CGT IS HERE<\/b>,” the forum will bring together a Nobel Laureate, industry pioneers, and investors to explore how today’s innovations can evolve into tomorrow’s standards of care.<\/p>\n
RSVP: http:\/\/bit.ly\/467jaet<\/a><\/p>\n (Register with\u00a0code GSGM1<\/b> to claim a complimentary ticket – limited to the first 20 registrants)<\/p>\n Meet Keynote Speakers<\/b><\/p>\n Get the latest news Sign up for The Manila Times newsletters<\/p>\n By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service<\/a> and Privacy Policy<\/a>.<\/p>\n The forum is honored to feature an extraordinary assembly of pioneering minds, headlined by Nobel Laureate Dr. Craig Mello<\/b>, acclaimed for his co-discovery of RNA interference which revolutionized genetic research and paved the way for an entire class of RNA-based therapeutics. He will explore how foundational science can transition into real clinical impact.<\/p>\n Dr. Carl June<\/b>, Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies, University of Pennsylvania. His groundbreaking work led to the first FDA-approved CAR-T cell therapy, reshaping modern cancer treatment. Dr. June will present the latest advances and future directions in cellular immunotherapies.<\/p>\n Dr. Miguel Forte<\/b>\u00a0, current President of the International Society for Cell & Gene Therapy (ISCT). With deep expertise in clinical translation and regulatory strategy, he will offer a global perspective on clinical translation, manufacturing (CMC) challenges, and regulatory pathways that will shape the scalability and accessibility of CGT.<\/p>\n The Afternoon <\/b>and<\/b>\u00a0Evening Program will Feature:<\/b><\/p>\n Focused Discussions on Industry Priorities<\/b><\/p>\n The forum’s agenda will address the topics that matter most to the CGT ecosystem, including:<\/p>\n In today’s rapidly evolving CGT industry, opportunities and challenges exist side by side. The GenScript Biotech Global Forum London 2025 offers a top-tier platform to directly engage with world-leading scientists, industry pioneers, and investors.<\/p>\n Registration is Now Open<\/b><\/p>\n Date:<\/b>Thursday, November 20, 2025<\/p>\n Location:<\/b> 116 Pall Mall, London, UK<\/p>\n
\n
\n delivered to your inbox<\/p>\n\n
\n